Indication
Streptococcus pneumoniae bronchitis
*Streptococcus pneumoniae* bronchitis is a non-invasive lower respiratory tract infection characterized by acute or chronic inflammation of the tracheobronchial tree caused by the Gram-positive bacterium *Streptococcus pneumoniae*. Read more about Streptococcus pneumoniae bronchitis
162 drugs 68 manufacturers
Drugs that treat it
Common Streptococcus pneumoniae bronchitis therapies.
CEFDINIR
CEFDINIR
CEFDINIR
CEFDINIR
CEFDINIR
CEFDINIR
CLARITHROMYCIN
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soon*Streptococcus pneumoniae* bronchitis is a non-invasive lower respiratory tract infection characterized by acute or chronic inflammation of the tracheobronchial tree caused by the Gram-positive bacterium *Streptococcus pneumoniae*.
The condition predominantly affects adults with underlying cardiopulmonary diseases—such as chronic obstructive pulmonary disease—as well as pediatric populations presenting with protracted bacterial bronchitis.
Pathophysiologically, pneumococcal colonization and adherence to the bronchial epithelium trigger an inflammatory cascade and mucosal hypersecretion without advancing to alveolar consolidation.
Clinically, it manifests as a persistent, mucopurulent productive cough accompanied by dyspnea, wheezing, and low-grade systemic inflammation.
- clevelandclinic.org
*Streptococcus pneumoniae* bronchitis is a non-invasive lower respiratory tract infection characterized by acute or chronic inflammation of the tracheobronchial tree caused by the Gram-positive bacterium *Streptococcus pneumoniae* Pathophysiologically, pneumococcal colonization and adherence to the bronchial epithelium trigger an inflammatory cascade and mucosal hypersecretion without advancing to alveolar consolidation
- nhsinform.scot
*Streptococcus pneumoniae* bronchitis is a non-invasive lower respiratory tract infection characterized by acute or chronic inflammation of the tracheobronchial tree caused by the Gram-positive bacterium *Streptococcus pneumoniae* Clinically, it manifests as a persistent, mucopurulent productive cough accompanied by dyspnea, wheezing, and low-grade systemic inflammation
- fda.gov
The condition predominantly affects adults with underlying cardiopulmonary diseases—such as chronic obstructive pulmonary disease—as well as pediatric populations presenting with protracted bacterial bronchitis
- nih.gov
The condition predominantly affects adults with underlying cardiopulmonary diseases—such as chronic obstructive pulmonary disease—as well as pediatric populations presenting with protracted bacterial bronchitis
- nghs.com
Pathophysiologically, pneumococcal colonization and adherence to the bronchial epithelium trigger an inflammatory cascade and mucosal hypersecretion without advancing to alveolar consolidation Clinically, it manifests as a persistent, mucopurulent productive cough accompanied by dyspnea, wheezing, and low-grade systemic inflammation
Personalize your experience
Follow Streptococcus pneumoniae bronchitis and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.